LXEOLexeo Therapeutics, Inc.
- Market cap
- $229.85M
- as of 2026-10-23
- Latest close
- $2.80
- as of 2026-10-23
- Sector
- Healthcare
- as of 2026-10-24
- Industry
- Biotechnology
- as of 2026-10-24
Cluster
No cluster in the last 90 days under the default rule (14d · ≥2 insiders · all roles).
Form 4 historysince 2023-11-09
Dashed line = amended filing (Form 4/A)
| Insider | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| Townsend Richard NolanChief Executive Officer | Sep 24 | Sep 28 | A · derivative | 145,500 | $3.39 | $493,245 | 145,500 | No | Form 4 |
| Otero Jose ManuelChief Operating Officer | Sep 24 | Sep 28 | A · derivative | 54,750 | $3.39 | $185,603 | 54,750 | No | Form 4 |
| Tamayo Louis EdwardChief Financial Officer | Sep 24 | Sep 28 | A · derivative | 54,750 | $3.39 | $185,603 | 54,750 | No | Form 4 |
| Bhalla Narinder PalChief Medical Officer | Sep 24 | Sep 28 | A · derivative | 54,750 | $3.39 | $185,603 | 54,750 | No | Form 4 |
| Townsend Richard NolanChief Executive Officer | Sep 14 | Sep 28 | A | 2,306 | $2.64 | $6,088 | 376,778 | No | Form 4 |
| Otero Jose ManuelChief Operating Officer | Sep 14 | Sep 28 | A | 2,110 | $2.64 | $5,570 | 138,288 | No | Form 4 |
| Bhalla Narinder PalChief Medical Officer | Sep 14 | Sep 28 | A | 2,714 | $3.58 | $9,716 | 84,908 | No | Form 4 |
| Townsend Richard NolanChief Executive Officer | Aug 18 | Aug 19 | S | 3,345 | $4.95 | Sale −$16,558 | 374,472 | No | Form 4 |
| Otero Jose ManuelChief Operating Officer | Aug 18 | Aug 19 | S | 1,304 | $4.96 | Sale −$6,468 | 136,178 | No | Form 4 |
| Tamayo Louis EdwardChief Financial Officer | Aug 18 | Aug 19 | S | 4,117 | $4.91 | Sale −$20,214 | 92,907 | No | Form 4 |
| Townsend Richard NolanChief Executive Officer | Jul 1 | Jul 1 | S | 25,947 | $4.48 | Sale −$116,243 | 377,817 | No | Form 4 |
| Otero Jose ManuelChief Operating Officer | Jul 1 | Jul 1 | S | 4,666 | $4.48 | Sale −$20,904 | 137,482 | No | Form 4 |
| Tamayo Louis EdwardChief Financial Officer | Jul 1 | Jul 1 | S | 4,641 | $4.49 | Sale −$20,838 | 97,024 | No | Form 4 |
| Bhalla Narinder PalChief Medical Officer | Jul 1 | Jul 1 | S | 22,306 | $4.42 | Sale −$98,593 | 82,194 | No | Form 4 |
| Townsend Richard NolanChief Executive Officer | Jun 29 | Jul 1 | A | 67,000 | $0.00 | $0 | 403,764 | No | Form 4 |
| Otero Jose ManuelChief Operating Officer | Jun 29 | Jul 1 | A | 12,060 | $0.00 | $0 | 142,148 | No | Form 4 |
| Tamayo Louis EdwardChief Financial Officer | Jun 29 | Jul 1 | A | 12,000 | $0.00 | $0 | 101,665 | No | Form 4 |
| Bhalla Narinder PalChief Medical Officer | Jun 29 | Jul 1 | A | 55,000 | $0.00 | $0 | 104,500 | No | Form 4 |
| Cholmondeley Paula H | Jun 25 | Jun 29 | A · derivative | 35,000 | $4.70 | $164,500 | 35,000 | No | Form 4 |
| Diaz Reinaldo M | Jun 25 | Jun 29 | A · derivative | 35,000 | $4.70 | $164,500 | 35,000 | No | Form 4 |
| Altschuler Steven | Jun 25 | Jun 29 | A · derivative | 35,000 | $4.70 | $164,500 | 35,000 | No | Form 4 |
| Agger Mette Kirstine | Jun 25 | Jun 29 | A · derivative | 35,000 | $4.70 | $164,500 | 35,000 | No | Form 4 |
| Van Hauwermeiren Timothy | Jun 25 | Jun 29 | A · derivative | 35,000 | $4.70 | $164,500 | 35,000 | No | Form 4 |
| Tanguler Tolga | Jun 25 | Jun 29 | A · derivative | 35,000 | $4.70 | $164,500 | 35,000 | No | Form 4 |
| Cooperstone Brenda | Jun 25 | Jun 29 | A · derivative | 35,000 | $4.70 | $164,500 | 35,000 | No | Form 4 |
| Townsend Richard NolanChief Executive Officer | May 18 | May 20 | S | 3,342 | $5.06 | Sale −$16,911 | 336,764 | No | Form 4 |
| Otero Jose ManuelChief Operating Officer | May 18 | May 20 | S | 1,302 | $5.07 | Sale −$6,601 | 130,088 | No | Form 4 |
| Sepp-Lorenzino Laura | Apr 28 | Apr 30 | A · derivative | 50,000 | $5.81 | $290,500 | 50,000 | No | Form 4 |
| Townsend Richard NolanChief Executive Officer | Apr 6 | Apr 7 | S | 55,000 | $5.69 | Sale −$312,950 | 340,106 | Yes | Form 4 |
| Townsend Richard NolanChief Executive Officer | Mar 13 | Mar 17 | A | 2,623 | $2.64 | $6,925 | 395,106 | No | Form 4 |
| Otero Jose ManuelChief Operating Officer | Mar 13 | Mar 17 | A | 5,930 | $2.64 | $15,655 | 131,390 | No | Form 4 |
| Townsend Richard NolanChief Executive Officer | Feb 18 | Feb 20 | S | 10,173 | $6.38 | Sale −$64,904 | 392,483 | No | Form 4 |
| Otero Jose ManuelChief Operating Officer | Feb 18 | Feb 20 | S | 3,016 | $6.40 | Sale −$19,302 | 125,460 | No | Form 4 |
| Otero Jose ManuelChief Operating Officer | Nov 18, 2025 | Feb 204/A | S | 721 | $9.27 | Sale −$6,684 | 63,476 | No | Form 4/A |
| Bhalla Narinder PalChief Medical Officer | Feb 13 | Feb 17 | A | 49,500 | $0.00 | $0 | 49,500 | No | Form 4 |
| Bhalla Narinder PalChief Medical Officer | Feb 13 | Feb 17 | A · derivative | 297,000 | $6.31 | $1,874,070 | 297,000 | No | Form 4 |
| Townsend Richard NolanChief Executive Officer | Feb 4 | Feb 6 | A | 161,665 | $0.00 | $0 | 402,656 | No | Form 4 |
| Townsend Richard NolanChief Executive Officer | Feb 4 | Feb 6 | A · derivative | 646,665 | $7.27 | $4,701,255 | 646,665 | No | Form 4 |
| Otero Jose ManuelChief Operating Officer | Feb 4 | Feb 6 | A | 65,000 | $0.00 | $0 | 128,476 | No | Form 4 |
| Otero Jose ManuelChief Operating Officer | Feb 4 | Feb 6 | A · derivative | 260,000 | $7.27 | $1,890,200 | 260,000 | No | Form 4 |
| Tamayo Louis EdwardChief Financial Officer | Feb 4 | Feb 6 | A | 44,665 | $0.00 | $0 | 89,665 | No | Form 4 |
| Tamayo Louis EdwardChief Financial Officer | Feb 4 | Feb 6 | A · derivative | 226,665 | $7.27 | $1,647,855 | 226,665 | No | Form 4 |
| Adler EricChief Medical Officer | Nov 18, 2025 | Nov 20, 2025 | S | 615 | $9.27 | Sale −$5,701 | 72,646 | No | Form 4 |
| Robertson JennyChief Legal Officer | Nov 18, 2025 | Nov 20, 2025 | S | 549 | $9.27 | Sale −$5,089 | 68,381 | No | Form 4 |
| Townsend Richard NolanChief Executive Officer | Nov 18, 2025 | Nov 20, 2025 | S | 1,127 | $9.27 | Sale −$10,447 | 240,991 | No | Form 4 |
| See Tai SandiChief Development Officer | Nov 18, 2025 | Nov 20, 2025 | S | 386 | $9.27 | Sale −$3,578 | 65,476 | No | Form 4 |
| Adler EricChief Medical Officer | Oct 17, 2025 | Oct 17, 2025 | S | 3,344 | $8.94 | Sale −$29,895 | 73,299 | No | Form 4 |
| Adler EricChief Medical Officer | Oct 17, 2025 | Oct 17, 2025 | S | 38 | $9.56 | Sale −$363 | 73,261 | No | Form 4 |
| Robertson JennyChief Legal Officer | Oct 17, 2025 | Oct 17, 2025 | S | 3,486 | $8.94 | Sale −$31,165 | 68,970 | No | Form 4 |
| Robertson JennyChief Legal Officer | Oct 17, 2025 | Oct 17, 2025 | S | 40 | $9.56 | Sale −$382 | 68,930 | No | Form 4 |
| Townsend Richard NolanChief Executive Officer | Oct 17, 2025 | Oct 17, 2025 | S | 12,985 | $8.94 | Sale −$116,086 | 242,266 | No | Form 4 |
| Townsend Richard NolanChief Executive Officer | Oct 17, 2025 | Oct 17, 2025 | S | 148 | $9.56 | Sale −$1,415 | 242,118 | No | Form 4 |
| See Tai SandiChief Development Officer | Oct 17, 2025 | Oct 17, 2025 | S | 3,844 | $8.94 | Sale −$34,365 | 65,906 | No | Form 4 |
| See Tai SandiChief Development Officer | Oct 17, 2025 | Oct 17, 2025 | S | 44 | $9.56 | Sale −$421 | 65,862 | No | Form 4 |
| Otero Jose ManuelChief Technical Officer | Oct 17, 2025 | Oct 17, 2025 | S | 2,091 | $8.94 | Sale −$18,694 | 64,221 | No | Form 4 |
| Otero Jose ManuelChief Technical Officer | Oct 17, 2025 | Oct 17, 2025 | S | 24 | $9.56 | Sale −$229 | 64,197 | No | Form 4 |
| Adler EricChief Medical Officer | Oct 15, 2025 | Oct 17, 2025 | A | 9,570 | $0.00 | $0 | 76,643 | No | Form 4 |
| Robertson JennyChief Legal Officer | Oct 15, 2025 | Oct 17, 2025 | A | 9,900 | $0.00 | $0 | 72,456 | No | Form 4 |
| Townsend Richard NolanChief Executive Officer | Oct 15, 2025 | Oct 17, 2025 | A | 33,000 | $0.00 | $0 | 255,251 | No | Form 4 |
| See Tai SandiChief Development Officer | Oct 15, 2025 | Oct 17, 2025 | A | 10,890 | $0.00 | $0 | 69,750 | No | Form 4 |
| Otero Jose ManuelChief Technical Officer | Oct 15, 2025 | Oct 17, 2025 | A | 5,940 | $0.00 | $0 | 66,312 | No | Form 4 |
| Townsend Richard NolanChief Executive Officer | Sep 12, 2025 | Sep 16, 2025 | A | 2,193 | $2.64 | $5,790 | 222,251 | No | Form 4 |
| Townsend Richard NolanChief Executive Officer | Aug 18, 2025 | Sep 10, 20254/A | S | 1,115 | $4.67 | Sale −$5,207 | 220,058 | No | Form 4/A |
| Tamayo Louis EdwardChief Financial Officer | Aug 29, 2025 | Sep 3, 2025 | A | 45,000 | $0.00 | $0 | 45,000 | No | Form 4 |
| Tamayo Louis EdwardChief Financial Officer | Aug 29, 2025 | Sep 3, 2025 | A · derivative | 280,000 | $4.79 | $1,341,200 | 280,000 | No | Form 4 |
| See Tai SandiChief Development Officer | Aug 18, 2025 | Aug 20, 2025 | S | 382 | $4.67 | Sale −$1,784 | 58,860 | No | Form 4 |
| Adler EricChief Medical Officer | Aug 18, 2025 | Aug 20, 2025 | S | 608 | $4.67 | Sale −$2,839 | 67,073 | No | Form 4 |
| Robertson JennyChief Legal Officer | Aug 18, 2025 | Aug 20, 2025 | S | 542 | $4.67 | Sale −$2,531 | 62,556 | No | Form 4 |
| Otero Jose ManuelChief Technical Officer | Aug 18, 2025 | Aug 20, 2025 | S | 2,848 | $4.67 | Sale −$13,300 | 60,372 | No | Form 4 |
| Agger Mette Kirstine | Jun 26, 2025 | Jun 30, 2025 | A · derivative | 25,000 | $4.18 | $104,500 | 25,000 | No | Form 4 |
| Altschuler Steven | Jun 26, 2025 | Jun 30, 2025 | A · derivative | 25,000 | $4.18 | $104,500 | 25,000 | No | Form 4 |
| Cholmondeley Paula H | Jun 26, 2025 | Jun 30, 2025 | A · derivative | 25,000 | $4.18 | $104,500 | 25,000 | No | Form 4 |
| Cooperstone Brenda | Jun 26, 2025 | Jun 30, 2025 | A · derivative | 25,000 | $4.18 | $104,500 | 25,000 | No | Form 4 |
| Diaz Reinaldo M | Jun 26, 2025 | Jun 30, 2025 | A · derivative | 25,000 | $4.18 | $104,500 | 25,000 | No | Form 4 |
| Van Hauwermeiren Timothy | Jun 26, 2025 | Jun 30, 2025 | A · derivative | 22,916 | $4.18 | $95,789 | 22,916 | No | Form 4 |
| Tanguler Tolga | Jun 26, 2025 | Jun 30, 2025 | A · derivative | 14,583 | $4.18 | $60,957 | 14,583 | No | Form 4 |
| See Tai SandiChief Development Officer | May 16, 2025 | May 20, 2025 | S | 367 | $2.77 | Sale −$1,017 | 59,242 | No | Form 4 |
| Robertson JennyChief Legal Officer | May 16, 2025 | May 20, 2025 | S | 521 | $2.77 | Sale −$1,443 | 63,098 | No | Form 4 |
| Adler EricChief Medical Officer | May 16, 2025 | May 20, 2025 | S | 585 | $2.77 | Sale −$1,620 | 67,681 | No | Form 4 |
| Townsend Richard NolanChief Executive Officer | May 16, 2025 | May 20, 2025 | S | 1,074 | $2.77 | Sale −$2,975 | 221,173 | No | Form 4 |
| See Tai SandiChief Development Officer | Mar 14, 2025 | Apr 9, 2025 | A | 5,720 | $2.61 | $14,929 | 59,609 | No | Form 4 |
| Robertson JennyChief Legal Officer | Mar 14, 2025 | Apr 9, 2025 | A | 5,720 | $2.61 | $14,929 | 63,619 | No | Form 4 |
| Otero Jose ManuelChief Technical Officer | Mar 14, 2025 | Apr 9, 2025 | A | 5,720 | $2.61 | $14,929 | 63,220 | No | Form 4 |
| Townsend Richard NolanChief Executive Officer | Mar 14, 2025 | Apr 1, 2025 | A | 2,128 | $2.61 | $5,554 | 222,247 | No | Form 4 |
| Robertson JennyChief Legal Officer | Feb 19, 2025 | Feb 21, 2025 | S | 2,101 | $4.41 | Sale −$9,265 | 57,899 | No | Form 4 |
| Adler EricChief Medical Officer | Feb 19, 2025 | Feb 21, 2025 | S | 2,359 | $4.41 | Sale −$10,403 | 68,266 | No | Form 4 |
| See Tai SandiChief Development Officer | Feb 19, 2025 | Feb 21, 2025 | S | 1,486 | $4.41 | Sale −$6,553 | 53,889 | No | Form 4 |
| Townsend Richard NolanChief Executive Officer | Feb 19, 2025 | Feb 21, 2025 | S | 4,326 | $4.41 | Sale −$19,078 | 220,119 | No | Form 4 |
| Rasbach KyleChief Financial Officer | Jan 17, 2025 | Jan 22, 2025 | A | 40,875 | $0.00 | $0 | 40,875 | No | Form 4 |
| Rasbach KyleChief Financial Officer | Jan 17, 2025 | Jan 22, 2025 | A · derivative | 245,250 | $5.07 | $1,243,418 | 245,250 | No | Form 4 |
| Adler EricChief Medical Officer | Jan 7, 2025 | Jan 10, 2025 | A | 43,750 | $0.00 | $0 | 70,625 | No | Form 4 |
| Adler EricChief Medical Officer | Jan 7, 2025 | Jan 10, 2025 | A · derivative | 87,500 | $7.33 | $641,375 | 87,500 | No | Form 4 |
| See Tai SandiChief Development Officer | Jan 7, 2025 | Jan 10, 2025 | A | 38,750 | $0.00 | $0 | 55,375 | No | Form 4 |
| See Tai SandiChief Development Officer | Jan 7, 2025 | Jan 10, 2025 | A · derivative | 77,500 | $7.33 | $568,075 | 77,500 | No | Form 4 |
| Robertson JennyChief Legal & Admin Officer | Jan 7, 2025 | Jan 10, 2025 | A | 36,250 | $0.00 | $0 | 60,000 | No | Form 4 |
| Robertson JennyChief Legal & Admin Officer | Jan 7, 2025 | Jan 10, 2025 | A · derivative | 72,500 | $7.33 | $531,425 | 72,500 | No | Form 4 |
| Otero Jose ManuelChief Technical Officer | Jan 7, 2025 | Jan 10, 2025 | A | 26,250 | $0.00 | $0 | 57,500 | No | Form 4 |
| Otero Jose ManuelChief Technical Officer | Jan 7, 2025 | Jan 10, 2025 | A · derivative | 52,500 | $7.33 | $384,825 | 52,500 | No | Form 4 |
| Townsend Richard NolanChief Executive Officer | Jan 7, 2025 | Jan 10, 2025 | A | 103,750 | $0.00 | $0 | 224,445 | No | Form 4 |
| Townsend Richard NolanChief Executive Officer | Jan 7, 2025 | Jan 10, 2025 | A · derivative | 207,500 | $7.33 | $1,520,975 | 207,500 | No | Form 4 |
| Townsend Richard NolanChief Executive Officer | Dec 10, 2024 | Dec 12, 2024 | M | 2,500 | $2.33 | $5,825 | 123,195 | Yes | Form 4 |
| Townsend Richard NolanChief Executive Officer | Dec 10, 2024 | Dec 12, 2024 | S | 2,500 | $8.20 | Sale −$20,500 | 120,695 | Yes | Form 4 |
| Townsend Richard NolanChief Executive Officer | Dec 10, 2024 | Dec 12, 2024 | M · derivative | 2,500 | $2.33 | $5,825 | 118,655 | Yes | Form 4 |
| Cholmondeley Paula H | Nov 25, 2024 | Nov 26, 2024 | P | 15,000 | $6.99 | Purchase +$104,850 | 30,627 | No | Form 4 |
| Townsend Richard NolanChief Executive Officer | Nov 11, 2024 | Nov 13, 2024 | M | 2,500 | $2.33 | $5,825 | 123,195 | Yes | Form 4 |
| Townsend Richard NolanChief Executive Officer | Nov 11, 2024 | Nov 13, 2024 | S | 2,500 | $7.82 | Sale −$19,550 | 120,695 | Yes | Form 4 |
| Townsend Richard NolanChief Executive Officer | Nov 11, 2024 | Nov 13, 2024 | M · derivative | 2,500 | $2.33 | $5,825 | 121,155 | Yes | Form 4 |
| Tanguler Tolga | Nov 11, 2024 | Nov 13, 2024 | A · derivative | 36,000 | $7.95 | $286,200 | 36,000 | No | Form 4 |
| Townsend Richard NolanChief Executive Officer | Oct 10, 2024 | Oct 15, 2024 | M | 5,000 | $2.33 | $11,650 | 125,695 | Yes | Form 4 |
| Townsend Richard NolanChief Executive Officer | Oct 10, 2024 | Oct 15, 2024 | S | 5,000 | $8.10 | Sale −$40,500 | 120,695 | Yes | Form 4 |
| Townsend Richard NolanChief Executive Officer | Oct 10, 2024 | Oct 15, 2024 | M · derivative | 5,000 | $2.33 | $11,650 | 123,655 | Yes | Form 4 |
| Townsend Richard NolanChief Executive Officer | Sep 10, 2024 | Sep 11, 2024 | M | 5,000 | $2.33 | $11,650 | 125,695 | Yes | Form 4 |
| Townsend Richard NolanChief Executive Officer | Sep 10, 2024 | Sep 11, 2024 | S | 5,000 | $10.65 | Sale −$53,250 | 120,695 | Yes | Form 4 |
| Townsend Richard NolanChief Executive Officer | Sep 10, 2024 | Sep 11, 2024 | M · derivative | 5,000 | $2.33 | $11,650 | 128,655 | Yes | Form 4 |
| Townsend Richard NolanChief Executive Officer | Aug 12, 2024 | Aug 13, 2024 | M | 5,000 | $2.33 | $11,650 | 125,695 | Yes | Form 4 |
| Townsend Richard NolanChief Executive Officer | Aug 12, 2024 | Aug 13, 2024 | S | 5,000 | $11.53 | Sale −$57,650 | 120,695 | Yes | Form 4 |
| Townsend Richard NolanChief Executive Officer | Aug 12, 2024 | Aug 13, 2024 | M · derivative | 5,000 | $2.33 | $11,650 | 133,655 | Yes | Form 4 |
| Townsend Richard NolanChief Executive Officer | Jul 11, 2024 | Jul 12, 2024 | S | 27,931 | $17.06 | Sale −$476,503 | 120,795 | Yes | Form 4 |
| Townsend Richard NolanChief Executive Officer | Jul 11, 2024 | Jul 12, 2024 | S | 100 | $19.06 | Sale −$1,906 | 120,695 | Yes | Form 4 |
| Townsend Richard NolanChief Executive Officer | Jul 10, 2024 | Jul 12, 2024 | M | 5,000 | $2.33 | $11,650 | 175,695 | Yes | Form 4 |
| Townsend Richard NolanChief Executive Officer | Jul 10, 2024 | Jul 12, 2024 | S | 23,622 | $16.45 | Sale −$388,582 | 152,073 | Yes | Form 4 |
| Townsend Richard NolanChief Executive Officer | Jul 10, 2024 | Jul 12, 2024 | S | 3,347 | $16.85 | Sale −$56,397 | 148,726 | Yes | Form 4 |
| Townsend Richard NolanChief Executive Officer | Jul 10, 2024 | Jul 12, 2024 | M · derivative | 5,000 | $2.33 | $11,650 | 138,655 | Yes | Form 4 |
| Van Hauwermeiren Timothy | Jul 5, 2024 | Jul 8, 2024 | A · derivative | 36,000 | $15.49 | $557,640 | 36,000 | No | Form 4 |
| Agger Mette Kirstine | Jun 25, 2024 | Jun 27, 2024 | A · derivative | 18,000 | $16.87 | $303,660 | 18,000 | No | Form 4 |
| Cholmondeley Paula H | Jun 25, 2024 | Jun 27, 2024 | A · derivative | 18,000 | $16.87 | $303,660 | 18,000 | No | Form 4 |
| Diaz Reinaldo M | Jun 25, 2024 | Jun 27, 2024 | A · derivative | 18,000 | $16.87 | $303,660 | 18,000 | No | Form 4 |
| Altschuler Steven | Jun 25, 2024 | Jun 27, 2024 | A · derivative | 18,000 | $16.87 | $303,660 | 18,000 | No | Form 4 |
| Cooperstone Brenda | Jun 25, 2024 | Jun 27, 2024 | A · derivative | 18,000 | $16.87 | $303,660 | 18,000 | No | Form 4 |
| Otero Jose ManuelChief Technical Officer | Jun 12, 2024 | Jun 14, 2024 | A | 31,250 | $0.00 | $0 | 31,250 | Yes | Form 4 |
| Otero Jose ManuelChief Technical Officer | Jun 12, 2024 | Jun 14, 2024 | A · derivative | 187,500 | $18.19 | $3,410,625 | 187,500 | Yes | Form 4 |
| Townsend Richard NolanChief Executive Officer | Jun 10, 2024 | Jun 12, 2024 | M | 5,000 | $2.33 | $11,650 | 175,695 | Yes | Form 4 |
| Townsend Richard NolanChief Executive Officer | Jun 10, 2024 | Jun 12, 2024 | S | 2,962 | $17.29 | Sale −$51,213 | 172,733 | Yes | Form 4 |
| Townsend Richard NolanChief Executive Officer | Jun 10, 2024 | Jun 12, 2024 | S | 2,038 | $18.18 | Sale −$37,051 | 170,695 | Yes | Form 4 |
| Townsend Richard NolanChief Executive Officer | Jun 10, 2024 | Jun 12, 2024 | M · derivative | 5,000 | $2.33 | $11,650 | 143,655 | Yes | Form 4 |
| Townsend Richard NolanChief Executive Officer | May 13, 2024 | May 14, 2024 | M | 5,000 | $2.33 | $11,650 | 175,695 | Yes | Form 4 |
| Townsend Richard NolanChief Executive Officer | May 13, 2024 | May 14, 2024 | S | 5,000 | $13.22 | Sale −$66,100 | 170,695 | Yes | Form 4 |
| Townsend Richard NolanChief Executive Officer | May 13, 2024 | May 14, 2024 | M · derivative | 5,000 | $2.33 | $11,650 | 148,655 | Yes | Form 4 |
| Adler EricChief Medical Officer | Feb 2, 2024 | Feb 6, 2024 | A | 26,875 | $0.00 | $0 | 26,875 | No | Form 4 |
| Adler EricChief Medical Officer | Feb 2, 2024 | Feb 6, 2024 | A · derivative | 161,250 | $17.00 | $2,741,250 | 161,250 | No | Form 4 |
| Agger Mette Kirstine | Feb 2, 2024 | Feb 6, 2024 | A · derivative | 36,000 | $17.00 | $612,000 | 36,000 | No | Form 4 |
| Diaz Reinaldo M | Feb 2, 2024 | Feb 6, 2024 | A · derivative | 36,000 | $17.00 | $612,000 | 36,000 | No | Form 4 |
| Robertson JennyChief Legal and Admin Officer | Jan 5, 2024 | Jan 9, 2024 | A | 23,750 | $0.00 | $0 | 23,750 | Yes | Form 4 |
| Robertson JennyChief Legal and Admin Officer | Jan 5, 2024 | Jan 9, 2024 | A · derivative | 142,500 | $14.48 | $2,063,400 | 142,500 | Yes | Form 4 |
| Townsend Richard NolanChief Executive Officer | Jan 5, 2024 | Jan 9, 2024 | A | 43,750 | $0.00 | $0 | 170,695 | Yes | Form 4 |
| Townsend Richard NolanChief Executive Officer | Jan 5, 2024 | Jan 9, 2024 | A · derivative | 262,500 | $14.48 | $3,801,000 | 262,500 | Yes | Form 4 |
| Longitude Venture Partners IV, L.P. | Nov 7, 2023 | Nov 9, 2023 | C | 1,793,429 | not reported | not reported | 1,793,429 | No | Form 4 |
| Longitude Venture Partners IV, L.P. | Nov 7, 2023 | Nov 9, 2023 | C | 319,126 | not reported | not reported | 2,112,555 | No | Form 4 |
| Longitude Venture Partners IV, L.P. | Nov 7, 2023 | Nov 9, 2023 | P | 454,545 | $11.00 | Purchase +$4,999,995 | 2,567,100 | No | Form 4 |
| Longitude Venture Partners IV, L.P. | Nov 7, 2023 | Nov 9, 2023 | C · derivative | 18,999,999 | not reported | not reported | not reported | No | Form 4 |
| Longitude Venture Partners IV, L.P. | Nov 7, 2023 | Nov 9, 2023 | C · derivative | 2,906,148 | not reported | not reported | not reported | No | Form 4 |
| Lundbeckfond Invest A/S | Nov 7, 2023 | Nov 9, 2023 | C | 1,321,474 | not reported | not reported | 1,321,474 | No | Form 4 |
| Lundbeckfond Invest A/S | Nov 7, 2023 | Nov 9, 2023 | C | 287,213 | not reported | not reported | 1,608,687 | No | Form 4 |
| Lundbeckfond Invest A/S | Nov 7, 2023 | Nov 9, 2023 | P | 227,272 | $11.00 | Purchase +$2,499,992 | 1,835,959 | No | Form 4 |
| Lundbeckfond Invest A/S | Nov 7, 2023 | Nov 9, 2023 | C · derivative | 13,999,999 | not reported | not reported | not reported | No | Form 4 |
| Lundbeckfond Invest A/S | Nov 7, 2023 | Nov 9, 2023 | C · derivative | 2,615,533 | not reported | not reported | not reported | No | Form 4 |
| McCormac PaulChief Technical Officer | Nov 7, 2023 | Nov 9, 2023 | C | 3,191 | not reported | not reported | 17,349 | No | Form 4 |
| McCormac PaulChief Technical Officer | Nov 7, 2023 | Nov 9, 2023 | C · derivative | 29,061 | not reported | not reported | not reported | No | Form 4 |
| Paster Anne-Mari | Nov 7, 2023 | Nov 9, 2023 | C | 1,415,865 | not reported | not reported | 1,415,865 | No | Form 4 |
| Paster Anne-Mari | Nov 7, 2023 | Nov 9, 2023 | C | 287,213 | not reported | not reported | 1,703,078 | No | Form 4 |
| Paster Anne-Mari | Nov 7, 2023 | Nov 9, 2023 | P | 454,545 | $11.00 | Purchase +$4,999,995 | 2,157,623 | No | Form 4 |
| Paster Anne-Mari | Nov 7, 2023 | Nov 9, 2023 | C · derivative | 14,999,999 | not reported | not reported | not reported | No | Form 4 |
| Paster Anne-Mari | Nov 7, 2023 | Nov 9, 2023 | C · derivative | 2,615,533 | not reported | not reported | not reported | No | Form 4 |